As a major metabolic organ, the liver catalyzes dietary sugar, primarily encompassing glucose and fructose. Hepatocellular carcinoma (HCC) enhances glycolysis regardless of the oxygen supply. However, whether HCC, in contrast with normal liver tissue, has altered fructose metabolism and, if so, whether this altered carbohydrate metabolism contributes to tumorigenesis are unknown. Our preliminary results revealed that normal hepatocytes, which have high fructose metabolism rates, express the high-activity fructokinase (KHK) isoform KHK- C, a rate-limiting enzyme in fructose metabolism. In contrast, HCC cells have a much lower fructose metabolism rate, and this stitch of KHK isoform expression is mediated by heterogeneous nuclear ribonucleoprotein H1/2-dependent alternative splicing of the KHK gene, resulting in a switch from high-activity KHK-C to low-activity KHK-A isoform expression. Importantly, we demonstrated that KHK-A expression is required for production of nucleotides and nucleotide acid derived from glycolysis. We hypothesize that aberrant splicing of KHK coordinates the regulation of fructose metabolism and glycolysis-dependent de novo nucleic acid synthesis to promote HCC development. To test this hypothesis, we will pursue three specific aims: 1) determine the role of alternative splicing of KHK in the regulation of HCC metabolism, 2) determine the role of alternative KHK splicing and the significance of KHK-A? mediated PRPS1 phosphorylation in hepatocellular tumor growth, and 3) determine the role of fructose metabolism in hepatocellular tumor growth. The proposed research is significant because it may lead to pharmaceutical approaches to interrupting HCC metabolism by blocking the function of KHK-A. In turn, this would improve the efficacy of HCC treatment.

Public Health Relevance

Hepatocellular carcinoma (HCC) is the fifth most common malignancy worldwide. However, whether HCC, in contrast with normal liver tissue, alters fructose metabolism is unknown. In the proposed study, we will elucidate the mechanisms that underlie the coordinated regulation of glycolysis and fructose metabolism in HCC and this research may help us identify molecular markers of prognosis for HCC and lead to HCC therapies that are more effective than those used currently.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA204996-02
Application #
9397534
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Strasburger, Jennifer
Project Start
2016-12-15
Project End
2021-11-30
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Internal Medicine/Medicine
Type
Hospitals
DUNS #
800772139
City
Houston
State
TX
Country
United States
Zip Code
77030
Xia, Yan; Yang, Weiwei; Fa, Ming et al. (2017) RNF8 mediates histone H3 ubiquitylation and promotes glycolysis and tumorigenesis. J Exp Med 214:1843-1855
Li, Xinjian; Yu, Willie; Qian, Xu et al. (2017) Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and Autophagy. Mol Cell 66:684-697.e9
Qian, Xu; Li, Xinjian; Cai, Qingsong et al. (2017) Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. Mol Cell 65:917-931.e6
Li, Xinjian; Qian, Xu; Peng, Li-Xia et al. (2016) A splicing switch from ketohexokinase-C to ketohexokinase-A drives hepatocellular carcinoma formation. Nat Cell Biol 18:561-71
Liang, Ji; Cao, Ruixiu; Zhang, Yajuan et al. (2016) PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis. Nat Commun 7:12431